Vagus Nerve Stimulation vns Market Size, Share, Growth and Global Industry Analysis By Type & Application, Regional Insights and Forecast to 2024-2032

Growth Factors of Vagus Nerve Stimulation Market

The vagus nerve stimulation market size was valued at USD 505.2 million in 2018, and the market is now projected tgrow USD 2294.3 million in 2032 exhibiting a CAGR of 11.4% during the forecast period of 2019-2032.

The coronavirus has affected the vagus nerve stimulation (VNS) market ta considerable extent. Remote therapeutic procedures such as VNS implantation and other elective surgeries and non-emergency treatments were therefore postponed or withdrawn with health care facilities being stretched in covid19 cases. This in effect of a temporary slowdown in market growth. This was particularly the case for neurological and mental health ailments which have risen post-pandemic alongside heightened awareness of noninvasive VNS forms of treatment. Also, improvements in telemonitoring and tele adjustment have been possible because of newer VNS gadgets backed up by telemedicine improvements.

Vagus nerve stimulation (VNS) deliver electrical current tthe vagus nerve thus controlling some functions of the brain. One of the traditional approaches is implants with leads on the nerve used for stimulation in a controlled manner. As technology progresses, new, small, and more efficient VNS devices providing added clinical advantages, including decreased invasiveness and increased patient comfort, have been concurrently developed. These advancements meet the increased customer needs for the latest technology in the production of medical devices. Therefore, it is believed that greater use of modern VNS devices will continue tbe a major factor in the increase of the global market over the years.

Changing from the traditional medication tVagus Nerve Stimulation or VNS has brought new horizons tepilepsy, treatment resistant depression, and other neurological diseases. VNS is most appropriate in patients whdnot have a favorable response tepilepsy medications or antidepressants. The increase in the neurological disorder cases and TRD has made care providers shift telectrical stimulation devices. This trend strengthens the idea that the usage of VNS is applicable for the efficient management of these conditions. As a result, the market is expected twitness strong growth in years tcome, and hence the VNS Market.

Comprehensive Analysis of Vagus Nerve Stimulation Market

The vagus nerve stimulation market growth is rising at an exponential rate due tits market segmentation. This market expansion rightly provides a thorough market breakdown near tthe industry considering the leading supply and demand forces. These segmentations are methodically segregated by type analysis, by application analysis, and by end-use analysis. By type analysis includes invasive and non-invasive. By application analysis includes epilepsy, treatment resistant depression, and others. By end-use analysis includes neurology, cardiology, and other.

The North America region lead the vagus nerve stimulation market share by benefitting a market size of USD 244.7 million in 2018 due tits developing healthcare infrastructure.

The top players in the markets have a central responsibility in the healthcare industry tbe sure of industrial prospectus development and testablish the market norms. These players include, LivaNova PLC, BioControl, electroCore, Inc., Parasym Ltd, Innovative Health Solutions Inc., and tVNS Technologies GmbH these market players provide a level-playing competitive landscape.

In June 2019, Innovative Health Solutions Inc. received US FDA approval for IB-Stim treduce abdominal pain in children aged 11-18 with irritable bowel syndrome (IBS).

Segmentation Table

ATTRIBUTE DETAILS

Study Period - 2015-2026

Base Year - 2018

Forecast Period - 2019-2026

Historical Period - 2015-2017

Unit - Value (USD million)

Segmentation By Type

• Invasive
• Non-invasive (tVNS)

By Application

• Epilepsy
• Treatment Resistant Depression (TRD)
• Others

By End User

• Hospitals
• Specialty Clinics

By Geography

• North America (U.S. and Canada)
• Europe (U.K., Germany, France, Italy, Spain, Scandinavia, and Rest of Europe)
• Asia-Pacific (Japan, China, India, Australia, Southeast Asia, and Rest of Asia- Pacific)
• Latin America (Brazil, Mexico, and Rest of Latin America)
• Middle East & Africa (South Africa, GCC and Rest of Middle East & Africa)

Please Note: It will take 5-6 business days to complete the report upon order confirmation.